Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma

CN Qian, X Guo, B Cao, EJ Kort, CC Lee, J Chen… - Cancer research, 2002 - AACR
… the correlation between Met protein expression and survival time in 66 … protein expression
was inversely correlated with survival time. The patients with higher Met protein expression

Low p27 expression predicts poor disease-free survival in patients with prostate cancer

RM YANG, J NAITOH, M MURPHY… - The Journal of …, 1998 - auajournals.org
… of p27 protein expression in prostate cancer have been reported. The study of p27 expression
in … We examined the expression of p27 protein in 86 patients with clinically organ confined …

Gene-expression profiles predict survival of patients with lung adenocarcinoma

DG Beer, SLR Kardia, CC Huang, TJ Giordano… - Nature medicine, 2002 - nature.com
… of expression related to patient survival. One pattern, designated 'outlier', included genes
showing substantially elevated expression (… CDC6 protein expression was also substantially …

MYC and BCL 2 protein expression predicts survival in patients with diffuse large B‐cell lymphoma treated with rituximab

AM Perry, Y Alvarado‐Bernal, JA Laurini… - British journal of …, 2014 - Wiley Online Library
… In this study, we investigated whether MYC and BCL2 protein expression in tissue would
predict survival in DLBCL. The study included 106 cases of de novo DLBCL treated with …

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

Y Natkunam, P Farinha, ED Hsi, CP Hans… - Journal of Clinical …, 2008 - ascopubs.org
… We conclude that LMO2 protein expression is a prognostic marker in DLBCL patients treated
protein expression may become a practical assay for newly diagnosed DLBCL patients to …

p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases.

C Belluco, JG Guillem, N Kemeny, Y Huang… - Journal of clinical …, 1996 - ascopubs.org
… for p53 protein was found in 72% of cases. The pattern of p53 protein expression in lymph
node … The median survival time was 21.0 months in patients with p53-positive tumors and 53.2 …

High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma

MK Ang, MR Patel, XY Yin, S Sundaram, K Fritchie… - Clinical Cancer …, 2011 - AACR
… role and thus affect XRCC1 protein expression levels. Other studies have … protein expression
status and survival, we were not able to show any relationship between XRCC1 expression

Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving …

C Aschele, D Debernardis, S Lonardi… - Journal of clinical …, 2004 - ascopubs.org
survival time of almost 2 years that was observed in the group with positive DCC protein
expression … 1 and compares well even with the survival time achieved with more aggressive …

Rad51 protein expression and survival in patients with glioblastoma multiforme

JW Welsh, RK Ellsworth, R Kumar, K Fjerstad… - International Journal of …, 2009 - Elsevier
… also had increased survival, but patients with reduced Rad51 levels had shortened survival,
consistent with our findings of Rad51 expression at the initial diagnosis. This survival trend …

PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma

WQ Li, N Hu, VH Burton, HH Yang, H Su… - … , biomarkers & prevention, 2014 - AACR
… in ESCC tumors, nor did we find a significant association between PLCE1 protein expression
in GC tumors and survival. Inconsistencies between mRNA and protein results are not …